Session will showcase the rapidly growing use and groundbreaking impact of clinical genomics in oncology SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it will feature Dr. Karen Knudsen, CEO of the American Cancer Society, at its inaugural Illumina Genomics Forum (IGF) on October 1. […]
This approval marks the Oncomine Dx Target Test’s 8th CDx therapy selection indication CARLSBAD, Calif. — The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to identify patients whose tumors have a HER2 (ERBB2) activating mutations (SNVs & Exon 20 Insertion) in […]
New deal strengthens Congenica’s presence in India CAMBRIDGE, England — Congenica, a digital health company that enables precision medicine through its world-leading diagnostic decision support platform for genomic data, today announces a partnership with Avesthagen, a biotechnology major that specialises in predictive, preventive and personalised healthcare through the convergence of food, pharma and population genetics. […]
StarBright Violet 760, StarBright UltraViolet 575, and StarBright UltraViolet 605 Dyes Conjugated to Highly Validated Antibodies for Multicolor Panel Design in Immunology Research HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today extended its range of StarBright Dyes to provide greater flexibility […]
San Diego, CA – Proteintech Group today announces that it has established a new subsidiary company, Proteintech Genomics, based out of the thriving life sciences hub of San Diego, California. Proteintech Genomics is building out fully optimized and highly multiplexed proteomic assays to enhance multiomic capabilities across a number of spatial and single cell analysis […]
Genovis has signed a long-term licensing and supply agreement with a US based biotech company for the supply of SmartEnzymesTM to be used in the manufacturing of a clinical therapeutic agent. The new customer represents Genovis’ second partner in the Bioprocess application area. The new partner will initially use the Genovis enzyme for the preclinical process […]
BOSTON — 908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announces that it has completed the acquisition of privately-held TRACE Analytics GmbH, based in Braunschweig, Germany, a provider of on-line analysis and sampling systems for biotech applications. 908 Devices expects the acquired technology to enable its mass spec […]
QIAseq Targeted DNA Pro Panels halve library preparation time for sequencing samples New low-input kit for RNA sequencing further expands QIAGEN’s universal NGS portfolio and reduces disposable plastics use by 90% Four million samples have been processed by growing range of QIAseq NGS panels running on any sequencer Hilden, Germany, and Germantown, Maryland — QIAGEN […]
Element Biosciences Inc., developer of the Element AVITI System, a new and disruptive DNA sequencing platform, announced today it will implement no price increases to the entire range of AVITI reagents, including the sequencing kit, the Adept™ and Elevate™ kits. This effort to democratize their technology and make it more broadly available and affordable, will take effect immediately […]
CYTENA’s B.SIGHTTM will reduce timelines and cut costs on single-cell microbiology research Freiburg, Germany -CYTENA, a BICO group company (Nasdaq Stockholm: BICO) and leading provider of high-precision instruments for handling biological cells, has launched a new instrument to streamline single-cell isolation in microbiology research. The next generation B.SIGHT is taking the company’s automated single-cell isolation capabilities […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
